EXONDYS 51 ETEPLIRSEN INJECTION holds 1 USPTO trademark filings across 0 NICE classes. The largest concentration is in Class 5 (Pharmaceuticals) with 1 filings. The WikiTrademarks Expansion Score is 1/100, low — the brand is focused on defending its existing categories rather than expanding.
USPTO data refreshed September 23, 2026
Protect or track "EXONDYS 51 ETEPLIRSEN INJECTION"
Watch this name and we'll alert you when anyone files a similar mark.
Informational only, not a legal opinion. Consult a trademark attorney before filing or enforcing.
Own this brand? Claim the profile to add your logo, story, and website.
Sign in to claimHow is EXONDYS 51 ETEPLIRSEN INJECTION filing trademarks, and where is the portfolio expanding?
Filing Velocity (24 Months)
Nice Class Distribution
Activity Timeline
No activity recorded yet.
Recent Filings
| Serial No. | Mark | Filing Date | Status | Classes | Owner |
|---|---|---|---|---|---|
| 87175636 | EXONDYS 51 ETEPLIRSEN INJECTION | Sep 19, 2016 | Pending | 005 Pharmaceuticals | Sarepta Therapeutics, Inc. |
Weekly visibility reports showing how ChatGPT mentions EXONDYS 51 ETEPLIRSEN INJECTION, where you rank in the answer, the sentiment of the mention, and which sources ChatGPT cites.
FAQ: EXONDYS 51 ETEPLIRSEN INJECTION trademark portfolio
What trademarks does EXONDYS 51 ETEPLIRSEN INJECTION hold?
EXONDYS 51 ETEPLIRSEN INJECTION holds 1 USPTO trademark filings across 0 NICE classes. The largest concentration is in Class 5 (Pharmaceuticals). The most recent filings are registered to Sarepta Therapeutics, Inc..
How many trademarks does EXONDYS 51 ETEPLIRSEN INJECTION have at the USPTO?
WikiTrademarks tracks 1 USPTO trademark filings attributed to EXONDYS 51 ETEPLIRSEN INJECTION. The brand has been actively filing since September 2016. The count updates daily as new filings are indexed from the USPTO bulk data feed.
In which NICE classes does EXONDYS 51 ETEPLIRSEN INJECTION file most often?
EXONDYS 51 ETEPLIRSEN INJECTION's most active class is NICE Class 5 (Pharmaceuticals), with 1 filings. The full distribution across all 0 classes is shown in the Nice Class Distribution panel on this page.
Who owns the EXONDYS 51 ETEPLIRSEN INJECTION trademark?
The most recent filings under the EXONDYS 51 ETEPLIRSEN INJECTION mark are registered to Sarepta Therapeutics, Inc.. Trademark ownership can shift through assignments — see the Ownership & Assignment History section on this page for the full chain of title.
Is EXONDYS 51 ETEPLIRSEN INJECTION expanding into new categories?
The current WikiTrademarks Expansion Score for EXONDYS 51 ETEPLIRSEN INJECTION is 1 out of 100, which is low — the brand is focused on defending its existing categories rather than expanding. The score combines NICE class breadth, filing velocity, and the rate of cross-class movement from the brand's filing history.
How can I track new EXONDYS 51 ETEPLIRSEN INJECTION trademark filings?
Click the Watch Brand button at the top of this page to add EXONDYS 51 ETEPLIRSEN INJECTION to your Watchlist. New filings show up on your WikiTrademarks dashboard within 24 to 48 hours of being public, alongside any class expansions, status changes, or assignment events.
More on this portfolio: Compare EXONDYS 51 ETEPLIRSEN INJECTION to another owner · Browse all NICE classes · Most valuable brands
Community notes
0 notesShare what you know about EXONDYS 51 ETEPLIRSEN INJECTION and help the next person researching it.